查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1761752

生物可吸收血管支架市場：全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2032）

Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 192 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球生物可吸收血管支架市場的綜合報告。該報告全面評估了關鍵市場動態，包括市場促進因素、趨勢、機會和挑戰，並深入分析了市場結構。研究報告提供了獨家數據和統計數據，概述了 2025 年至 2032 年全球生物可吸收血管支架市場的預測成長軌跡。

關鍵見解

  • 生物可吸收血管支架市場規模（2025年）：3.144億美元
  • 預計市場價值（2032年）：5.928億美元
  • 全球市場成長率（2025-2032年複合年成長率）：8.3%

生物可吸收血管支架市場研究範圍：

生物可吸收血管支架 (BVS) 是用於治療冠狀動脈疾病的先進醫療設備，它透過向血管提供臨時機械支撐同時在體內逐漸溶解。與傳統金屬支架不同，BVS 消除了與永久植入相關的長期併發症，例如晚期支架內血栓症。這些支架主要用於經經皮冠狀動脈介入治療 (PCI) 手術，越來越受到年輕患者和未來需要手術治療的患者的青睞。 BVS 市場提供由聚乳酸 (PLA)、聚碳酸酯和其他生物可吸收聚合物製成的創新支架，以滿足醫院、心血管專科中心和門診手術單位的需求。心血管疾病負擔的加重、對下一代支架技術的需求不斷成長以及向微創治療的轉變推動了市場擴張。

市場促進因素：

全球生物可吸收血管支架市場受多種關鍵因素驅動，例如冠狀動脈疾病盛行率的上升，尤其是在老化人口和高風險族群中。患者和醫生越來越偏好使用可最大限度減少長期併發症的臨時植入，這加速了生物可吸收血管支架（BVS）相對於傳統支架的普及。改進的支架設計、更優的藥物釋放型性能以及更快的分解速度等技術進步正在改善臨床療效並促進產品創新。此外，主要市場監管部門的積極核准以及心血管研究投資的不斷增加也支撐著市場的成長。由於醫療基礎設施的改善以及人們對先進心血管治療的認知不斷提高，新興經濟體的生物可吸收血管支架的普及率也不斷提高。

市場限制：

儘管生物可吸收血管支架市場成長潛力巨大，但其仍面臨著許多挑戰，例如設備成本高昂、報銷政策有限以及對支架強度和長期療效的擔憂。早期臨床試驗提出了關於支架血栓症形成的安全問題，影響了其早期應用。嚴格的安全評估和複雜的核准途徑等監管障礙，也為新參與企業帶來了更大的市場挑戰。此外，由於生物可吸收血管支架植入技術學習難度高，醫師的猶豫可能會限制市場擴張，尤其是在低度開發地區。透過改善培訓、提供透明的臨床數據和經濟高效的解決方案來解決這些問題，對於更廣泛的應用至關重要。

市場機會：

生物可吸收血管支架市場蘊含著巨大的機會，這得益於材料科學、生物分解性藥物傳遞系統以及精準介入心臟病學領域的技術創新。擴大使用先進的影像和診斷工具來支援支架的精準放置，從而提高了手術成功率和患者預後。醫療設備製造商與學術機構之間的合作正在推動性能更優、吸收速度更快的下一代支架的開發。隨著醫療保健系統轉向價值導向型護理，生物可吸收血管支架 (BVS) 有望降低長期併發症和再次手術率，使其成為一種經濟高效的長期解決方案。新興市場的擴張以及門診 PCI 手術的日益成長趨勢，為 BVS 提供了進一步的成長途徑。

本報告探討的關鍵問題

  • 推動全球生物可吸收血管支架市場成長的關鍵因素有哪些？
  • 哪些材料和技術引領 BVS 領域的創新？
  • 臨床結果和病人安全如何影響整個醫療保健系統對 BVS 的採用？
  • 誰是生物可吸收血管支架市場的主要貢獻者？他們採取了哪些策略措施來維持成長？
  • 全球 BVS 市場的新興趨勢和長期前景是什麼？

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 生物分解性聚合物和下一代支架設計的開發
    • 設計具有改進的生物相容性和可控分解速率的新型聚合物
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值洞察

  • 工具採用分析
  • 監管狀況
  • 價值鏈分析
  • PESTLE分析
  • 波特五力分析

第4章 2025 年定價分析

  • 主要亮點
  • 影響實施成本的關鍵因素
  • 依公司類型進行定價分析

第5章全球生物可吸收血管支架市場展望

  • 主要亮點
    • 市場規模預測
    • 市場規模及年成長率
    • 絕對的商機
  • 市場規模及數量分析與預測
    • 2019-2024 年歷史市場規模（百萬美元）分析
    • 2025-2032年市場規模（百萬美元）分析與預測
  • 全球生物可吸收血管支架市場展望：產品
    • 簡介/主要發現
    • 2019 年至 2024 年歷史市場規模（百萬美元）和銷售（單位）分析
    • 2025 年至 2032 年市場規模（百萬美元）與銷售量（單位）分析與預測
      • 金屬生物可吸收血管支架
      • 聚合物生物可吸收血管支架
    • 市場吸引力分析：產品
  • 全球生物可吸收血管支架市場展望：應用
    • 簡介/主要發現
    • 2019-2024 年歷史市場規模（百萬美元）分析
    • 2025-2032年市場規模（百萬美元）分析與預測
      • 周邊動脈
      • 冠狀動脈
    • 市場吸引力分析：應用
  • 全球生物可吸收血管支架市場展望：最終用戶
    • 簡介/主要發現
    • 2019-2024 年歷史市場規模（百萬美元）分析
    • 2025-2032年市場規模（百萬美元）分析與預測
      • 醫院
      • 門診手術中心
      • 心導管實驗室
      • 其他
    • 市場吸引力分析：最終用戶

6. 全球生物可吸收血管支架市場展望-地區

  • 主要亮點
  • 2019 年至 2024 年市場規模與數量趨勢分析
  • 2025-2032 年市場規模及數量分析及預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

7. 北美生物可吸收血管支架市場展望

8. 歐洲生物可吸收血管支架市場展望

第9章東亞生物可吸收血管支架市場展望

10.南亞和大洋洲生物可吸收血管支架市場展望

第11章拉丁美洲生物可吸收血管支架市場展望

12. 中東和非洲生物可吸收血管支架市場展望

第13章競爭格局

  • 2025年市場佔有率分析
  • 市場結構
    • 市場競爭加劇圖
    • 競爭儀錶板
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Meril Life Sciences Pvt. Ltd.
    • Zeus Company LLC
    • Biotronik
    • Abbott
    • MicroPort Scientific Corporation
    • Kyoto Medical
    • Elixir Medical
    • Cigna
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • REVA Medical

第14章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP34715

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bioresorbable vascular scaffold market from 2025 to 2032.

Key Insights:

  • Bioresorbable Vascular Scaffold Market Size (2025E): USD 314.4 Million
  • Projected Market Value (2032F): USD 592.8 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 8.3%

Bioresorbable Vascular Scaffold Market - Report Scope:

Bioresorbable vascular scaffolds (BVS) are advanced medical devices used to treat coronary artery disease by providing temporary mechanical support to blood vessels while gradually dissolving in the body. Unlike traditional metallic stents, BVS eliminate the long-term complications associated with permanent implants, such as late stent thrombosis. These scaffolds are primarily utilized in percutaneous coronary intervention (PCI) procedures and are increasingly preferred for younger patients or those requiring future surgical options. The BVS market caters to hospitals, specialty cardiovascular centers, and ambulatory surgical units, offering innovative scaffolds made from polylactic acid (PLA), polycarbonate, and other bioresorbable polymers. Market expansion is driven by a growing burden of cardiovascular diseases, increased demand for next-generation stent technologies, and a shift toward minimally invasive treatment options.

Market Growth Drivers:

The global bioresorbable vascular scaffold market is propelled by several key factors, including the rising prevalence of coronary artery disease, especially in aging and high-risk populations. Increasing patient and physician preference for temporary implants that minimize long-term complications has accelerated the adoption of BVS over traditional stents. Technological advancements, including improved scaffold designs, enhanced drug-eluting properties, and faster degradation rates, are enhancing clinical outcomes and driving product innovation. Furthermore, favorable regulatory approvals in major markets and growing investment in cardiovascular research are supporting market growth. Emerging economies are also witnessing increased adoption due to the rise in healthcare infrastructure and awareness of advanced cardiovascular therapies.

Market Restraints:

Despite its strong growth potential, the bioresorbable vascular scaffold market faces challenges related to high device costs, limited reimbursement policies, and concerns about scaffold strength and long-term efficacy. Initial clinical trials raised safety issues regarding scaffold thrombosis, which impacted early adoption. Regulatory hurdles, including stringent safety evaluations and complex approval pathways, add to market entry challenges for new players. Additionally, physician hesitancy due to the steep learning curve associated with BVS implantation techniques can restrict market expansion, particularly in underdeveloped regions. Addressing these issues through improved training, transparent clinical data, and cost-effective solutions remains essential for broader acceptance.

Market Opportunities:

The bioresorbable vascular scaffold market presents significant opportunities driven by innovations in material science, biodegradable drug delivery systems, and precision-based cardiovascular interventions. The increasing use of advanced imaging and diagnostic tools to support accurate scaffold placement enhances procedural success and patient outcomes. Collaborations between medical device manufacturers and academic institutions are fueling the development of next-generation scaffolds with optimized performance and faster resorption rates. As healthcare systems shift toward value-based care, the potential for reduced long-term complications and repeat procedures positions BVS as a cost-effective solution over time. Expansion into emerging markets and the rising trend of outpatient PCI procedures offer further growth avenues.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
  • Which materials and technologies are leading innovation in the BVS sector?
  • How are clinical outcomes and patient safety influencing the adoption of BVS across healthcare systems?
  • Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategic moves are they making to sustain growth?
  • What are the emerging trends and long-term prospects in the global BVS market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in R&D to enhance scaffold performance, reduce resorption time, and improve patient outcomes. Strategic partnerships with hospitals, research organizations, and cardiovascular societies facilitate clinical adoption and expand global reach. Additionally, market participants are prioritizing physician education programs, post-marketing surveillance studies, and expansion into high-growth regions to strengthen their market position and drive the transition toward bioresorbable technologies in cardiovascular care.

Key Companies Profiled:

  • Meril Life Sciences Pvt. Ltd.
  • Zeus Company LLC
  • Biotronik
  • Abbott
  • MicroPort Scientific Corporation
  • Kyoto Medical
  • Elixir Medical (MedImpact Healthcare Systems, Inc.)
  • Cigna
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • REVA Medical

Bioresorbable Vascular Scaffold Market Research Segmentation:

The bioresorbable vascular scaffold market encompasses a variety of materials, technologies, applications, and end-user segments tailored to the evolving needs of cardiovascular intervention.

By Product

  • Metal Bioresorbable Vascular Scaffold
  • Polymer Bioresorbable Vascular Scaffold

By Application

  • Peripheral Artery
  • Coronary Artery

By End-user

  • Hospitals
  • Ambulatory Care Centers
  • Cardiac Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-economic Factors
    • 2.3.1. The development of biodegradable polymers and next-gen scaffold designs
    • 2.3.2. Engineering of novel polymers with improved biocompatibility and controlled degradation rates
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Tool Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Deployment Costs
  • 4.3. Pricing Analysis, By Enterprise Type

5. Global Bioresorbable Vascular Scaffold Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Metal Bioresorbable Vascular Scaffold
      • 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Bioresorbable Vascular Scaffold Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Peripheral Artery
      • 5.4.3.2. Coronary Artery
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Bioresorbable Vascular Scaffold Market Outlook: End-user
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Ambulatory Surgical Centers
      • 5.5.3.3. Cardiac Catheterization Labs
      • 5.5.3.4. Others
    • 5.5.4. Market Attractiveness Analysis: End-user

6. Global Bioresorbable Vascular Scaffold Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Bioresorbable Vascular Scaffold Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End-user
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1.
      • 7.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 7.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Peripheral Artery
    • 7.5.2. Coronary Artery
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Surgical Centers
    • 7.6.3. Cardiac Catheterization Labs
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Bioresorbable Vascular Scaffold Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End-user
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1.
      • 8.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 8.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, Application, 2025-2032
    • 8.5.1. Peripheral Artery
    • 8.5.2. Coronary Artery
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Surgical Centers
    • 8.6.3. Cardiac Catheterization Labs
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Bioresorbable Vascular Scaffold Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End-user
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1.
      • 9.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 9.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Peripheral Artery
    • 9.5.2. Coronary Artery
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Cardiac Catheterization Labs
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End-user
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1.
      • 10.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 10.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Peripheral Artery
    • 10.5.2. Coronary Artery
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Surgical Centers
    • 10.6.3. Cardiac Catheterization Labs
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Bioresorbable Vascular Scaffold Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End-user
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1.
      • 11.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 11.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Peripheral Artery
    • 11.5.2. Coronary Artery
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Surgical Centers
    • 11.6.3. Cardiac Catheterization Labs
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End-user
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1.
      • 12.4.1.1. Metal Bioresorbable Vascular Scaffold
      • 12.4.1.2. Polymer Bioresorbable Vascular Scaffold
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Peripheral Artery
    • 12.5.2. Coronary Artery
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Surgical Centers
    • 12.6.3. Cardiac Catheterization Labs
    • 12.6.4. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Meril Life Sciences Pvt. Ltd.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Deployments
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Zeus Company LLC
    • 13.3.3. Biotronik
    • 13.3.4. Abbott
    • 13.3.5. MicroPort Scientific Corporation
    • 13.3.6. Kyoto Medical
    • 13.3.7. Elixir Medical
    • 13.3.8. Cigna
    • 13.3.9. B. Braun Melsungen AG
    • 13.3.10. Boston Scientific Corporation
    • 13.3.11. REVA Medical

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations